|
Mikhailova N.A.
Roxadustat: treatment of anemia and additional clinical effects (literature review)
|
№2 / 2024
|
|
Butranova O.I., Zyryanov S.K.
Quality of life in diabetic patients with chronic kidney disease
|
№1 / 2024
|
|
Zeinebekova A.B., Umarova A.M., Usmanova D.U., Turkara A.M., Kovalchuk V.E., Dyussenova S.B.
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus
|
№1 / 2023
|
|
Tishkina S.V., Mikhailova N.A., Kartsev A.M., Tishkina A.V., Pushkina A.V., Derinova E.A.
Сorrection of nutritional status violations by a diet in patiets on maintenance hemodialysis with and without diabetes type 2
|
№1 / 2022
|
|
M.S. Shamkhalova, I.A. Sklyanik, M.V. Shestakova
Beyond glycemic control: nephroprotective effects of glucagon-like peptide 1 receptor agonists
|
№3 / 2021
|
|
M.V. Amosova, O.Yu. Gurova
Kidney damage in type 2 diabetes mellitus: is it diabethic nephropathy only?
|
№4 / 2017
|
|
N.A. Mihajlova, S.V. Tishkina
Features in managing patients with chronic kidney disease and type 2 diabetes: the need for a multidisciplinary approach
|
№2 / 2016
|
|
S.S. Nagaitseva, M.Yu. Shvetsov, A.N Gerasimov, Yu.D Shalyagin, E.S. Ivanova, E.M. Shilov
Use of survey in chronic kidney disease stratification
|
№1 / 2014
|
|
V.V. Fomin
Urinary tract infections in diabetes mellitus and metabolic syndrome: role of combined phytotherapy
|
№4 / 2013
|
|
G.A. Alexandrovich, E.I. Andreeva, A.S. Markov, N.N. Morozova, G.A. Saneeva, I.A. Unanova
Role of sulodexide in treatment of diabetic nephropathy in patients with type 1 diabetes mellitus
|
№1 / 2012
|
|
Moisseev S.V., Fomin V.V., Saginova E.A.
The HOPE Study: putting it’s experience into clinical practice
|
№3 / 2009
|
Русский
